Israel, China team hopes to crack cure for advanced-stage solid tumors
Israel's Enlivex Therapeutics and China's BeiGene teamed up to study combining macrophage reprogramming and an anti-PD-1 immune checkpoint inhibitor.
A doctor prepares to administer Allocetra. (Illustrative photo) Updated: